See also this year's filing and all EDGAR filings for this company.
PDF Report 0001346302_2021_Xeris_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001346302, Xeris Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 152,212,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,707,000 |
| 3 | remainder_Assets | 232,000 |
| 4 | LiabilitiesCurrent | 28,207,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 97,183,000 |
| 7 | CostOfGoodsAndServicesSold | 9,328,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 73,732,000 |
| 9 | ResearchAndDevelopmentExpense | 20,921,000 |
| 10 | remainder_Expenses | -110,000 |
| 11 | remainder_Revenues | 20,155,000 |
| 12 | remainder_NetIncome | -7,424,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 159,151,000 |
| 1 | Liabilities | 125,390,000 |
| 2 | Expenses | 103,871,000 |
| 3 | Revenues | 20,155,000 |
| 4 | StockholdersEquity | 33,761,000 |
| 5 | NetIncome | -91,140,000 |
| 6 | ComprehensiveNetIncome | -91,140,000 |
| 7 | BaseVar | 207,995,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.123 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
